Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Media, Education & EngagementEducational Platforms & ResourcesOnline Resources
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing
Media, Education & EngagementEducational Platforms & Resources
Media, Education & Engagement

Stanford University

United States
8 Trials2 Papers

At the Stanford School of Medicine, researchers from the Rodriguez Lab and the Heifets Lab have united under the banner of the Stanford Psychedelic Science Group. Their primary clinical focus is to investigate compounds including ketamine, psilocybin, and MDMA as potential treatments for debilitating disorders such as obsessive-compulsive disorder (OCD), treatment-resistant depression, and post-traumatic stress disorder (PTSD).

Course Provider

0 active

Active Courses

0

Upcoming Cohorts

0

Evergreen

0

Price Range

Varies

Course Status

Showing 0of 1linked courses for Stanford University.
No courses match the selected filters.

Academic Research

2 papers

Published Papers

2

Trial Involvement

8

Distinct Focus Topics

0

Latest Publication

Feb 21, 2026

Quick Facts

Type
academic
HQ
United States
Website
Visit

Sponsored Trials

7
Not yet recruitingII

Anesthesia-Masked Psilocybin Therapy for Major Depression

Start Date
Compounds
Psilocybin, Placebo
RecruitingII

Examining Mu Opioid Mechanisms of Ketamine’s Rapid Effects in OCD (MKET2) (MKET2)

Start Date
Compounds
Ketamine, Placebo
CompletedNA

Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure

Start Date
Compounds
Ibogaine, Placebo
CompletedNA

Stanford Reward Circuits of the Brain Study – MDMA

Start Date
Compounds
MDMA, Placebo
Active not recruitingIII

Opiate Suicide Study in Patients With Major Depression

Start Date
Compounds
Ketamine, Placebo
CompletedIV

Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery

Start Date
Compounds
Ketamine, Placebo
CompletedI

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

Start Date
Compounds
Ketamine, Placebo

Collaborated Trials

1
CompletedII

Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)

Start Date
Compounds
Ketamine, Placebo

Research Papers

2
Open Accessindividual

Increased cortical thickness and decreased brain age among special operations veterans with blast TBI after a magnesium-ibogaine protocol

This secondary analysis of an observational study (n=30) - named MISTIC - of Special Operations Forces veterans with blast-related traumatic brain injury, examined ibogaine given with magnesium and found increased cortical thickness, larger subcortical volumes and a lower estimated brain age one month later. The authors note that the MRI changes could reflect neuroplastic effects, although the scans may also be influenced by non-structural factors.

Published
Journal
iScience
Authors
Geoly, A. D., Coetzee, J. P., Buchanan, D. M., Struckmann, W., Kim, B., Sridhar, M., Azeez, A., Lissemore, J. I., Cherian, K., Faerman, A., Keynan, J. N., Singal, P., Shanbour, A., Bandeira, I. D., Kratter, I. H., Adamson, M. M., Saggar, M., Rolle, C., Williams, N. R.
Open Accessindividual

Magnesium-ibogaine therapy in veterans with traumatic brain injuries

This observational study (n=30) evaluates ibogaine (up to 980mg/70kg) in combination with magnesium (1-2 hours before and 12 hours later) in male Special Operations Forces veterans with predominantly mild traumatic brain injury (mTBI). The study assessed changes in disability, PTSD, depression, and anxiety immediately and one month after treatment using various scales. Results show significant improvements in functioning and psychological symptoms with no serious adverse events.

Published
Journal
Nature Medicine
Authors
Cherian, K. N., Keynan, J. N., Anker, L., Faerman, A., Brown, R. E., Shamma, A., Keynan, O., Coetzee, J. P., Batail, J. M., Phillips, A., Bassa, N. J., Sahlem, G. L., Inzunza, J., Millar, T., Dickinson, J., Rol, C. E., Keller, J., Adamson, M., Kratter, I. H., Williams, N. R.